Treatment of multiple gingival recessions with xenogeneic acellular dermal matrix compared to connective tissue graft: a randomized split-mouth clinical trial

CONCLUSIONS: The use of PADM to treat multiple recessions improved clinical parameters at 12 months, but these outcomes were nevertheless poorer than those observed for CTG. However, PADM reduced morbidity, particularly the pain experienced by patients.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03162016.PMID:33913631 | PMC:PMC8090794 | DOI:10.5051/jpis.2002400120
Source: Journal of Periodontal and Implant Science - Category: Dentistry Authors: Source Type: research